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Summary: We investigated the effect of the pretreatment (sonification or centrifugation) of saliva samples on
the concentration of several steroid hormones as measured with highly specific RIA after extraction and
chromatography. It appeared that sonification of saliva resulted in significantly higher values for progesterone,
cortisone, 17-hydroxyprogesterone, testosterone and oestradiol (10 — 49% increase), compared with the levels
recorded after centrifugation. No differences were demonstrated for the concentrations of cortisol and
androstenedione, except that a sex-dependent difference effect was observed in the values for androstenedione:
concentrations measured in sonificated male saliva were lower than those measured in supernatant saliva.
Introduction
Hitherto, the rationale of steroid assays in saliva was
based on several assumptions:
1. that the plasma free, protein-unbound, apolar ste-
roid hormones freely diffuse through the salivary
gland,
2. that the concentrations of these steroids in saliva
are comparable to their plasma free levels,
3. that steroid binding proteins are absent from saliva
(1,2).
Indeed, many authors report a very close relationship
between the plasma free and salivary concentrations
of several endogenous steroids, synthetic steroids and
even drugs (3 — 9). The very fast (infusion-studies)
and flow rate-independent appearance of apolar ste-
roids in saliva strengthened the idea of an unham-
pered diffusion from plasma to saliva (10). In those
cases where salivary concentrations did not reflect
their plasma free levels, or where plasma free and
salivary concentrations were quite different, this was
explained by assuming the presence of steroid metab-
olizing enzyme activities in the salivary gland or by
methodological imperfection (11 — 15).
However, it was later demonstrated that steroids in
saliva exist only partly in the unbound state (4, 16 —
20). The assumption that only apolar, lipid-soluble or
small polar compounds could enter the saliva by
diffusion or ultrafiltration, respectively, had to be
reconsidered when several plasma proteins were de-
tected in saliva (21 —28). The most disturbing finding,
which may result in a re-evaluation of the current
concepts in salivary steroid assay, is the detection of
specific steroid binding proteins in saliva: corticoste-
roid binding globulin, sex hormone binding globulin,
aldosterone binding globulin (29 — 32). According to
Chu & Ekins (1989), corticosteroid binding globulin
in saliva, which is highly dependent on flow-rate, is
not merely a contamination, but should be regarded
as a secretion product, originating from plasma.
The generally applied technique of saliva preparation
before assay is freezing, thawing and centrifugation,
which produces a clear, easily pipe.ttable supernatant.
Freezing and thawing of saliva, however, results in
precipitation of globular proteins (23), whereas cen-
trifugation leads to a considerable loss in protein
content (33). If specific steroid binding proteins are
present in saliva the preparation of samples before
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assay may greatly influence the results of steroid hor-
mone determinations, especially when direct assays
are used. We were interested in whether the method
of pretreatment of salivary samples (centrifugation or
sonification) would influence the concentrations of
several steroid hormones, which were assayed with
highly specific RIA after extraction and chromatog-
raphy.
Materials and Methods
Subjects
For this study 111 healthy, non-medicated subjects volunteered
for the collection of saliva. The group consisted of 20 men, 17
pregnant women and 74 non-pregnant women, aged 15 — 60
years.
Sample collection
Each subject provided a sample of 15—20 ml of saliva. Citric
acid grains were applied to the tongue to stimulate flow and
the saliva was spat into plastic cups. After sampling, the saliva
was immediately frozen and kept at —20 °C until analysis.
Procedures
Salivary steroid concentration, were measured by RIA after
prior extraction and paper chromatography. The methods used
have been previously described in detail (3, 6, 7, 34). Aliquots
(3 ml) of saliva were incubated with tritiated recovery tracer
(± 10000 dpm each), which was used to monitor procedural
losses. After extraction of the samples, the dried extracts were
applied to Whatman No. 1 paper and chromatographed in the
appropriate descending Bush solvent system: Bush B5 toluene/
methanol/water 2:1:1 (v/v) for cortisol and cortisone; Bush B3
light petroleum (80-110 °C)/toluene/methanol/water 333:167:
400:100 (v/v) for progesterone, testosterone and oestradiol;
modified Bush A light petroleum (80-110 °C)/methanol/water
9:7:4 (v/v) for 17-hydroxyprogesterone and androstenedione.
The tritiated hormone areas were located by radioscanning and
eluted. The eluates were used for recovery counting and RIA.
The in-house RIA procedures were optimized for the very low
concentrations of the steroids in saliva. Dextran-coated char-
coal was used for separation of the free and antiserum bound
fraction. The analytical variables are summarized in table 2.
Statistics
For the statistical analysis of the results we used Pearson regres-
sion analysis and Wilcoxon signed rank test.
Sample preparation
The saliva samples were thawed at room temperature. After
thorough mixing, each sample was divided in two portions.
One portion was centrifuged for 10 minutes at 1500g, which
yielded a clear saliva supernatant. The other portion was son-
ificated (2 times 30 seconds) with a MSB Soniprep 150 (MSB
Scientific Instruments, Manor Royal, Crawley, Sussex, Eng-
land) and was referred to as whole saliva.
Materials
Chromatography solvents were of „Baker Analyzed" grade (J.
T. Baker Chemical Co., Phillipsburg, NJ). All other chemicals
were analytical grade. The pure steroids were purchased from
Steraloids (Steraloids INC., Wilton, NH). Tritiated cortisol,
cortisone, testosterone, progesterone, androstenedione and oes-
tradiol were purchased from New England Nuclear Corp.,
Boston, MA. Tritiated 17ot-hydroxyprogesterone was from
Amersham Int. PLC, Amersham, England. The cortisol and
cortisone antisera were a gift from Prof. Vecsei, Heidelberg;
testosterone antiserum was a gift from Dr. Pratt, Groningen,
The Netherlands; progesterone and oestradiol antiserum were
from Organon, Oss, The Netherlands; androstenedione anti-
serum was purchased from Radio Assay Systems Laboratories
Inc., Carson, CA; 17-hydroxyprogesterone antiserum was raised
in sheep in the endocrinology division. More details are shown
in table 1.
Results
The results of the determinations of the steroids in
whole saliva and in supernatant saliva are presented
in table 3. Correlations between concentrations in
whole saliva and supernatant saliva were all highly
significant.
In order to demonstrate differences between the con-
centrations of the several steroid hormones in whole
saliva and supernatant saliva, we calculated for each
subject the relative increase after sonification of the
samples (supernatant saliva = 100%). These data are
shown in table 4.
It appeared that sonification of saliva samples resulted
in a statistically significant increase in concentrations
of the steroid hormones, with the exception of cortisol
and androstenedione. Our study group, however, was
quite heterogeneous. The subjects were divided into
pregnant women, non-pregnant women and men. In
the pregnant group the results for progesterone and
Tab. 1. Tracers and antisera: HS = hemisuccinate, CET = carboxy-ethyl-thioether, CME = carboxy-methyl-ether, CMO
carbo'xy-methyl-oxime, BSA = bovine serum albumin.
Tracer Specific activity Immunogen Antiserum titer
[l,2,6,7-3H]Cortisol
[l,2-3H]Cortisone
[1,2,6,7-3H]Testosterone
[1,2,6,7-3H]Progesterone
[1,2,6,7-3H]Hydroxyprogesterone
[1,2,6,7-3H]Androstenedione
[l,2,6,7-3H]Oestradiol
3.1 MBq/mmol Cortisol-21-HS-BSA 22.500
1.1 MBq/mmol Cortisone-21-HS-BSA 15000
3.8 MBq/mmol Testosterone-7oc-CET-BSA 99000
3.3 MBq/mmol Progesterone-11-HS-BSA 862000
2.0 MBq/mmol ll-Deoxycortisol-21-HS-BSA 336000
3.1 MBq/mmol Androstenedione-19-CME-BS A 7600
3.8 MBq/mmol Oestradiol-6-CMO-BSA 88000
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Tab. 2. Analytical variables: Bush = chromatography system (see Methods); % B0 = % binding without standard; % NSB =
% non-specific binding; Blanco = water blank of the assay (pg/tube); Detection limit = detection limit of the assay
pg/tube (3xSD of the B0); Standards = range of standard curve (pg/tube); Tracer = tracer used for recovery and RIA
(see table 1); Buffer = buffer solution for tracer and antiserum; A = 0.1 mol/1 borate buffer, l g/l Beriglobin, pH 8.0;
B = 0.1 mol/1 borate buffer, 5 g/1 bovine serum albumin, pH 8.O.
Steroid
Chromatography
%B0
% NSB
Blanco
Detection limit
% Recovery
Standards
Tracer
Buffer
Intra-assay % CV
Inter-assay % CV
Cortisol
Bush B5
51
1.3
2.1
2.0
69
10-800
4x 3H
A
5.9
4.9
Cortisone
Bush B5
37
1.3
1.1
4.9
69
10-800
2χΉ
A
5.2
13
Testosterone
Bush B3
33
3.1
0.3
1.4
43
0.5-200
4χΉ
Β
7.1
7.7
Progesterone
Bush B3
41
4.3
5.0
2.2
61
0.5-200
4χΉ
Β
6.7
8.1
Hydroxy-
progesterone
Bush A
38
1.8
5.4
1.4
56
0.5-200
4χΉ
A
6.3
6.4
Andro-
stenedione
Bush A
45
6.0
3.6
2.3
44
0.5-200
4χΉ
A
5.0
8.6
Oestradiol
Bush B3
42
2.2
1.2
0.9
35
0.5-200
4χΉ
A
11
10
Tab. 3. Concentrations (mean ± SEM) of steroids in whole saliva and supernatant saliva: n = number of subjects, r = correlation
(Pearson) between individual steroid levels in whole saliva and supernatant saliva assay, * = p < 0.0001.
Steroid Whole saliva
n Mean + SEM Range
Supernatant saliva
n Mean ± SEM Range
Progesterone
Cortisol
Cortisone
Androstenedione
Hydroxyprogester-
one
Testosterone
Oestradiol
(nmol/1)
(nmol/1)
(nmol/1)
(nmol/1)
(nmol/1)
(nmol/1)
(pmol/1)
64
82
84
46
47
54
72
0.90
8.14
19.2
0.96
0.17
0.13
43.4
± 0.17
± 0.88
± 1.24
+ 0.13
± 0.03
+ 0.02
± 7.3
0.03 -
0.30 -
1.30 -
0.10 -
0.01 -
0.014-
2.6 -
5.54
35.4
49.2
3.60
1.20
0.59
314
60
80
81
46
46
50
65
0.49
8.10
17.6
1.13
0.16
0.12
29.5
+ 0.10
±0.93
± 1.24
+ 0.17
± 0.03
+ 0.018
± 4.7
0.02- 3.39
0.30- 43.0
1.40- 47.7
0.10- 4.70
0.01- 1.25
0.01 - 0.43
2.0 -228
0.9735*
0.9862*
0.9529*
0.9830*
0.9729*
0.9827*
0.9618*
Tab. 4. Relative difference between whole saliva and superna-
tant saliva (mean ± SEM): n = number of subjects,
P = probability of Wilcoxon signed rank test, ns = not
significant.
Steroid n Increase (%)
Progesterone
Cortisol
Cortisone
Androstenedione
Hydroxyprogesterone
Testosterone
Oestradiol
59
80
81
44
46
50
56
36 ± 0.06
-1 + 0.01
10 ± 0.02
-4 + 0.03
17 ± 0.06
22 ± 0.05
49 ± 0.15
< 0.0001
ns
< 0.0001
ns
< 0.0025
< 0.0001
0.02
oestradiol were higher in sonificated than in centri-
fuged saliva (increase 46 ± 10%, p < 0.0001 and
29 ±4%, p < 0.001, respectively), whereas for the
other steroids there was no significant difference. The
values for oestradiol in non-pregnant female saliva,
show differences between sonificated and centrifuged
samples as similar to those observed in pregnancy
samples; but this interpretation is preliminary, because
despite very low sensitivity the levels approximate the
detection limit of the assay. In male saliva the most
striking difference between whole saliva and super-
natant saliva was a decrease (14 ± 4%, p < 0.005) in
androstenedione values after sonification of saliva,
which was not observed for female non-pregnant sa-
liva.
Discussion
The present study clearly demonstrates the effect of
sample preparation on the concentrations of steroid
hormones measured in saliva. In our study group as
a whole, sonification of saliva yielded significantly
higher levels of steroids than centrifugation, with the
exception of cortisol and androstenedione. For these
latter hormones the method of sample preparation
had no influence on the results. Considering the
groups of pregnant women, non-pregnant women and
men separately, the most striking observation was a
decrease in androstenedione concentrations in male
saliva after sonification. It is possible that sonificating
the saliva samples disperses some unknown sub-
J. Clin. Chem. Clin. Biochem. / Vol. 28, 1990 / No. 12
926 Meulenberg and Hofman: Pretreatment of saliva
•δ
•Ξ· 5
1-
o-l
0 1 2 3 A
Progesterone (sample centrifuged) [nmol/l]
13
l 21
φ
·§.Ι 1-
0 1 2 3 A 5
Androstenedione (sample centrifuged) [nmol/l]
40
Ϊ 30
§20}
Φ
10
1.21
=•50
30
10 20 30 40
Cortisol (sample centrifuged) [nmol/l]
0 10 20 30 40 50
Cortisone (sample centrifuged) [nmol/l]
o.6
'S,0.2
50
Fig. 1. Correlation between concentrations of steroid
hormones in sonified and centrifuged saliva. Regression
equation and correlation coefficients are:
a. Progesterone: y = 1.31 χ + 0.60; r = 0.9735
b. Cortisol: y = 0.90 χ + 0.50; r = 0.9862
c. Cortisone: y = 0.96 χ + 1.78; r = 0.9529
d. Androstenedione: y = 0.76 χ + 0.09; r = 0.9830
e. 17-Hydroxyprogesterone: y = 0.99 χ + 0.02;
r = 9729
f. Testosterone: y = 1.14 χ + 1.89; r = 9827
g. Oestradiol: y = 1.31 χ - 2.50; r = 0.9618.
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stance(s), which interferes in the RIA. It is worth
mentioning the results of Baxendale et al. (1982) (4),
who demonstrated a sex-dependent difference in sal-
ivary testosterone values when comparing chroma-
tographed and direct assays.
In the non-pregnant and male groups the effect of
sample preparation was rather similar to that in the
study group as a whole. In contrast, in the pregnant
group, sonification of saliva resulted in higher values
only for progesterone and oestradiol. The data for
progesterone are comparable to those of Lequin et al.
(1986) (17) and indicate a loss of steroid hormone
when saliva is centrifuged. It is possible that the
pelleted debris of saliva contains most of the binding
proteins, which are precipitated by the process of
freezing and thawing of saliva (23), whereas centrif-
ugation leads to a further loss of such proteins (33).
Our findings indicate that caution is warranted in the
interpretation of data from salivary steroid hormone
determinations. If indeed specific steroid binding pro-
teins are present in saliva (31) the question of whether
the salivary hormone concentrations reflect the
plasma free levels has to be re-openend. The question
arises as to which of the analysed materials, whole
saliva or supernatant saliva, gives a real indication of
the plasma free level. Assuming that the decrease in
steroid concentrations in supernatant saliva is caused
by the removal of specific binding proteins, we tend
to believe that the latter is the better candidate, despite
lower absolute values for the steroid hormones.
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